ResearcherUniversità degli studi di Cassino e del Lazio MeridionaleNo recent work listed
Francesco Izzo
Matched on ORCID iD 0000-0003-3093-5408; OpenAlex author ID A5091003529. Sources: OpenAlex.
Their work
- Papers
- 18 (first author 0, last author 12)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 11
2015: 3 papers · 2016: 4 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper
Papers 18
- Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. Last author DOI 10.3390/cancers15020351↗
- Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. Last author DOI 10.3389/fonc.2022.955444↗
- Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective". Last author DOI 10.5114/pjr.2022.123567↗
- Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. Co-author DOI 10.3390/jcm10061305↗
- A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Ca… Co-author DOI 10.3390/jcm10174011↗
- Magnetic resonance imaging in the assessment of pancreatic cancer with quantitative parameter extraction by means of dynamic contrast-enhanced magnetic resonan… Co-author DOI 10.1177/1756284819885052↗
- Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma". Last author DOI 10.1245/s10434-020-09183-1↗
- Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge. Last author DOI 10.3389/fonc.2020.560952↗
- Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer. Last author DOI 10.2478/raon-2019-0004↗
- An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer Co-author DOI 10.1701/2715.27715↗
- Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. Co-author DOI 10.3748/wjg.v23.i26.4767↗
- The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Last author DOI 10.1155/2016/8352684↗
- Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Co-author DOI 10.1186/s13027-016-0105-6↗
- Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Last author DOI 10.1515/raon-2016-0003↗
- Curcumin AntiCancer Studies in Pancreatic Cancer. Last author DOI 10.3390/nu8070433↗
- Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Last author DOI 10.1016/j.ijsu.2015.04.055↗
- Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Last author DOI 10.1016/j.ijsu.2015.04.095↗
- Inhibitory effect of (-)-epigallocatechin-3-gallate and bleomycin on human pancreatic cancer MiaPaca-2 cell growth. Last author DOI 10.1186/s13027-015-0016-y↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Raffaéle Palaia · 17 shared papers, 2015–2023 · strength 1.79
- Paper Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cance… DOI 10.3389/fonc.2022.955444↗
- Paper Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspectiv… DOI 10.5114/pjr.2022.123567↗
- Paper Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. DOI 10.3390/cancers15020351↗
- Vincenza Granata · 17 shared papers, 2015–2023 · strength 1.75
- Paper Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cance… DOI 10.3389/fonc.2022.955444↗
- Paper Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspectiv… DOI 10.5114/pjr.2022.123567↗
- Paper Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. DOI 10.3390/cancers15020351↗
- Antonella Petrillo Petrillo · 14 shared papers, 2015–2023 · strength 1.18
- Paper Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. DOI 10.3390/cancers15020351↗
- Paper Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of… DOI 10.1245/s10434-020-09183-1↗
- Paper Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electr… DOI 10.3390/jcm10061305↗
- Antonio Avallone · 4 shared papers, 2020–2023 · strength 0.47
- Paper Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. DOI 10.3390/cancers15020351↗
- Paper Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electr… DOI 10.3390/jcm10061305↗
- Paper A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Tre… DOI 10.3390/jcm10174011↗
- Sabrina Bimonte · 5 shared papers, 2015–2017 · strength 0.28
- Paper An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in… DOI 10.1701/2715.27715↗
- Paper Curcumin AntiCancer Studies in Pancreatic Cancer. DOI 10.3390/nu8070433↗
- Paper The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. DOI 10.1155/2016/8352684↗
- Salvatore Tafuto · 2 shared papers, 2015–2021 · strength 0.16
- Mario De Bellis · 1 shared paper, 2023 · strength 0.15
- Luca Brunese · 1 shared paper, 2020 · strength 0.11
- Steven A. Curley · 1 shared paper, 2020 · strength 0.10
- Arturo Cuomo · 1 shared paper, 2017 · strength 0.08
- Claudio Arra · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.